Havas Worldwide in Mumbai has been appointed as its integrated communications partner by the Jaslok Hospital and Research Center.
Confirming the appointment, CEO, Jaslok Hospital and Research Center, Dr. Tarang Gianchandani said, "A brand like Jaslok needs a keen understanding of healthcare communication as well as the ability to understand how technology is changing the consumers' interaction with the category. In Havas Worldwide, we are happy to have found a partner who has both."
Indian Drug Firm Jubilant Collaborates With Cyclopharm to Market Technegas in the US
Technegas, an imaging agent primarily used in Pulmonary Embolism(blockage of lung arteries)is currently sold in 55 countries like EU, Japan and Canada by CYC.
Advertisement
Nirmalya Sen, Chief Executive Officer of Havas Worldwide India, said, "Healthcare is a major area of focus for Havas Worldwide globally. And we are delighted to partner Jaslok Hospital, among the most iconic brands in the space. At the heart of its success lies in decades of providing the highest standards of cure and care, while continually staying abreast with the latest in medical technology. We are delighted to be chosen to partner this iconic brand."
Jaslok Hospital was set up in 1973 with a very simple mission. To ensure that the best possible medical care using state-of-the-art technology to every single patient, irrespective of their social background or financial ability. Forty one years after Jaslok's inception, it is as acknowledged as a provider of high level of care, as for its charitable trust makes it possible for it to provide free or highly subsidized care to the poorest and most needy.
Source: AdAge India Bureau
Source: AdAge India Bureau
Swiss Drug Firm Collaborates With Amgen to Develop Treatments for Alzheimer's Disease
Novartis and California-based biotech company Amgen will jointly develop neuroscience treatments for illnesses like Alzheimer's disease and migraine headaches.
Advertisement
 Sanofi Collaborates With German Biotech Company to Develop a New Class of Diabetes DrugsThe collaboration will enhance Sanofi's extensive diabetes portfolio and will extend Evotec's metabolic disease and stem cell-based drug discovery programs. | Advertisement
|
Delhi Government Collaborates With Charitable Clinics to Expand Health Infrastructure
Indian health department has issued tenders inviting proposals for collaboration with charitable dispensaries to enhance patient care and medical services.
Advertisement